Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Dec;71(12):9223–9230. doi: 10.1128/jvi.71.12.9223-9230.1997

Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase.

J W Ding 1, Q Ning 1, M F Liu 1, A Lai 1, J Leibowitz 1, K M Peltekian 1, E H Cole 1, L S Fung 1, C Holloway 1, P A Marsden 1, H Yeger 1, M J Phillips 1, G A Levy 1
PMCID: PMC230225  PMID: 9371581

Abstract

Activation of the immune coagulation system has been implicated in the pathogenesis of fulminant liver failure caused by murine hepatitis virus strain 3 (MHV-3). The recent discovery of the fgl2 gene, which encodes for MHV-3-induced prothrombinase (fgl2 prothrombinase), allows for fundamental studies to determine the molecular basis for fulminant liver failure. Transcription of the fgl2 gene and translation of the protein it encodes were examined in the liver and other organs of susceptible mice following MHV-3 infection. No constitutive expression of the fgl2 gene or the fgl2 prothrombinase was detected. Within 12 to 24 h of MHV-3 infection, however, fgl2 gene transcripts were detected in large amounts in the liver, spleen, and lungs, all of which are rich in reticuloendothelial cells, but were only focally present in small amounts in the kidney and brain. There was sequential detection of fgl2 prothrombinase in the liver, where it was localized specifically to the endothelium of intrahepatic veins and hepatic sinusoids; this was allowed by fibrin deposition, which resulted in confluent hepatocellular necrosis. These results provide further evidence for the role of the selective expression of this novel fgl2 prothrombinase in the pathogenesis of MHV-3-induced fulminant liver failure.

Full Text

The Full Text of this article is available as a PDF (1.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abecassis M., Falk J. A., Makowka L., Dindzans V. J., Falk R. E., Levy G. A. 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest. 1987 Sep;80(3):881–889. doi: 10.1172/JCI113147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alexander H. R., Sheppard B. C., Jensen J. C., Langstein H. N., Buresh C. M., Venzon D., Walker E. C., Fraker D. L., Stovroff M. C., Norton J. A. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis. J Clin Invest. 1991 Jul;88(1):34–39. doi: 10.1172/JCI115298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buchmeier M. J., Lewicki H. A., Talbot P. J., Knobler R. L. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984 Jan 30;132(2):261–270. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Evans R., Kamdar S. J. Stability of RNA isolated from macrophages depends on the removal of an RNA-degrading activity early in the extraction procedure. Biotechniques. 1990 Apr;8(4):357–360. [PubMed] [Google Scholar]
  5. Fleming J. O., Shubin R. A., Sussman M. A., Casteel N., Stohlman S. A. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 1989 Jan;168(1):162–167. doi: 10.1016/0042-6822(89)90415-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fung L. S., Neil G., Leibowitz J., Cole E. H., Chung S., Crow A., Levy G. A. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection. J Biol Chem. 1991 Jan 25;266(3):1789–1795. [PubMed] [Google Scholar]
  7. Houtman J. J., Fleming J. O. Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol. 1996 Dec;2(6):361–376. doi: 10.3109/13550289609146902. [DOI] [PubMed] [Google Scholar]
  8. Janousek J., Strmen E., Gervais F. Purification of murine Kupffer cells by centrifugal elutriation. J Immunol Methods. 1993 Aug 26;164(1):109–117. doi: 10.1016/0022-1759(93)90281-b. [DOI] [PubMed] [Google Scholar]
  9. Koyama T., Hall L. R., Haser W. G., Tonegawa S., Saito H. Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains. Proc Natl Acad Sci U S A. 1987 Mar;84(6):1609–1613. doi: 10.1073/pnas.84.6.1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lamontagne L., Jolicoeur P. Mouse hepatitis virus 3-thymic cell interactions correlating with viral pathogenicity. J Immunol. 1991 May 1;146(9):3152–3159. [PubMed] [Google Scholar]
  11. Laskin D. L. Nonparenchymal cells and hepatotoxicity. Semin Liver Dis. 1990 Nov;10(4):293–304. doi: 10.1055/s-2008-1040485. [DOI] [PubMed] [Google Scholar]
  12. Levy G. A., Helin H., Edgington T. S. The pathobiology of viral hepatitis and immunologic activation of the coagulation protease network. Semin Liver Dis. 1984 Feb;4(1):59–68. doi: 10.1055/s-2008-1040646. [DOI] [PubMed] [Google Scholar]
  13. Levy G. A., Leibowitz J. L., Edgington T. S. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med. 1981 Oct 1;154(4):1150–1163. doi: 10.1084/jem.154.4.1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Li C., Fung L. S., Chung S., Crow A., Myers-Mason N., Phillips M. J., Leibowitz J. L., Cole E., Ottaway C. A., Levy G. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection. J Exp Med. 1992 Sep 1;176(3):689–697. doi: 10.1084/jem.176.3.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. MacPhee P. J., Dindzans V. J., Fung L. S., Levy G. A. Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3. Hepatology. 1985 Jul-Aug;5(4):649–660. doi: 10.1002/hep.1840050422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mori W., Aoki N., Shiga J. Acute hepatic cell necrosis experimentally produced by viral agents in rabbits. Am J Pathol. 1981 Apr;103(1):31–38. [PMC free article] [PubMed] [Google Scholar]
  17. Mori W., Shiga J., Irie H. Shwartzman reaction as a pathogenetic mechanism in fulminant hepatitis. Semin Liver Dis. 1986 Aug;6(3):267–276. doi: 10.1055/s-2008-1040609. [DOI] [PubMed] [Google Scholar]
  18. Ohlsson K., Björk P., Bergenfeldt M., Hageman R., Thompson R. C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990 Dec 6;348(6301):550–552. doi: 10.1038/348550a0. [DOI] [PubMed] [Google Scholar]
  19. Parr R. L., Fung L., Reneker J., Myers-Mason N., Leibowitz J. L., Levy G. Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity. J Virol. 1995 Aug;69(8):5033–5038. doi: 10.1128/jvi.69.8.5033-5038.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Patton J. S., Peters P. M., McCabe J., Crase D., Hansen S., Chen A. B., Liggitt D. Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents. J Clin Invest. 1987 Dec;80(6):1587–1596. doi: 10.1172/JCI113245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pope M., Rotstein O., Cole E., Sinclair S., Parr R., Cruz B., Fingerote R., Chung S., Gorczynski R., Fung L. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication. J Virol. 1995 Sep;69(9):5252–5260. doi: 10.1128/jvi.69.9.5252-5260.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Portmann B., Talbot I. C., Day D. W., Davidson A. R., Murray-Lyon I. M., Williams R. Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters. J Pathol. 1975 Nov;117(3):169–181. doi: 10.1002/path.1711170307. [DOI] [PubMed] [Google Scholar]
  23. Qureshi S. T., Clermont S., Leibowitz J., Fung L. S., Levy G., Malo D. Mouse hepatitis virus-3 induced prothrombinase (Fgl2) maps to proximal chromosome 5. Genomics. 1995 Sep 1;29(1):307–309. doi: 10.1006/geno.1995.1256. [DOI] [PubMed] [Google Scholar]
  24. Seglen P. O. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res. 1973 Dec;82(2):391–398. doi: 10.1016/0014-4827(73)90357-1. [DOI] [PubMed] [Google Scholar]
  25. Tracey K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R. J., Fahey T. J., 3rd, Zentella A., Albert J. D. Shock and tissue injury induced by recombinant human cachectin. Science. 1986 Oct 24;234(4775):470–474. doi: 10.1126/science.3764421. [DOI] [PubMed] [Google Scholar]
  26. Tracey K. J., Lowry S. F., Fahey T. J., 3rd, Albert J. D., Fong Y., Hesse D., Beutler B., Manogue K. R., Calvano S., Wei H. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet. 1987 May;164(5):415–422. [PubMed] [Google Scholar]
  27. Wang D., Yeger H., Cutz E. Expression of gastrin-releasing peptide receptor gene in developing lung. Am J Respir Cell Mol Biol. 1996 May;14(5):409–416. doi: 10.1165/ajrcmb.14.5.8624245. [DOI] [PubMed] [Google Scholar]
  28. Zimmerman H. J., Ishak K. G. Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology. 1982 Sep-Oct;2(5):591–597. doi: 10.1002/hep.1840020513. [DOI] [PubMed] [Google Scholar]
  29. de Souza M. S., Smith A. L., Bottomly K. Infection of BALB/cByJ mice with the JHM strain of mouse hepatitis virus alters in vitro splenic T cell proliferation and cytokine production. Lab Anim Sci. 1991 Apr;41(2):99–105. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES